Addressing HCV infection in Europe: Reported, estimated and undiagnosed cases

Central European Journal of Public Health

Volumn 16, Issue 3, 2008, Pages 106-110

  Merkinaite, Simona ^a   Lazarus, Jeffrey V ^b   Gore, Charles ^c,d  

^a Eurasian Harm Reduction Network   (Lithuania)

^b WORLD HEALTH ORGANIZATION   (Switzerland)

^c Hepatitis C Trust   (United Kingdom)

^d World Hepatitis Alliance   (United Kingdom)

Author keywords

Central and eastern europe; Drug use; Europe; Health policy; Hepatitis C Prevalence

Indexed keywords

EID: 53749089682     PISSN: 12107778     EISSN: None     Source Type: Journal    
DOI: 10.21101/cejph.a3482     Document Type: Article

References (22)

1. World Health Organization. Management of hepatitis C and HIV coinfection: clinical protocol for the WHO European Region. Copenhagen: WHO Regional Office for Europe; 2007.
2. Joint United Nations Programme on HIV/AIDS and the World Health Organization. AIDS Epidemic update: December 2007. Geneva: UNAIDS; 2007.
3. Trépo C, Pradat P. Hepatitis C virus infection in Western Europe. J Hepatol. 1999;31 Suppl 1:80-3.
4. Deuffic-Burban S, Mohamed MK, Larouze B, Carrat F, Valleron AJ. Expected increase in hepatitis C-related mortality in Egypt due to pre-2000 infections. J Hepatol. 2006 Mar;44(3):455-61.
5. Michielsen P, Bottieau E. Therapy of chronic hepatitis C in the setting of HIV co-infection. Acta Gastroenterol Belg. 2005 Jan-Mar;68(1):86-91.
6. Edlin BR. Hepatitis C prevention and treatment for substance users in the United States: acknowledging the elephant in the living room. Int J Drug Policy. 2004 Apr;15(2):81-91.
7. Lavanchy D. Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. J Viral Hepat. 2004 Mar;11(2):97-107.
8. Jongen-Hermus F. Correspondence based on data from the National Hepatitis Center, 2002 [personal correspondence]. Amsterdam: Soa AIDS Nederland; Aug 2007.
9. Mele A, Tosti ME, Spada E, Mariano A, Bianco E; SEIEVA collaborating group. Epidemiology of acute viral hepatitis: twenty years of surveillance through SEIEVA in Italy and a review of the literature. Report ISTISAN 06/12. Roma: Italian National Institute of Health; 2006.
10. Naoumov NV. Hepatitis C virus infection in Eastern Europe. J Hepatol. 1999;31 Suppl 1:84-7.
11. European Monitoring Centre for Drugs and Drug Addiction. Hepatitis C: a hidden epidemic. Drugs Focus. 2003 Nov-Dec;(6):1-4.
12. Desenclos JC. The challenge of hepatitis C surveillance in Europe. Euro Surveill. 2003 May;8(5):99-100.
13. Sweeting MJ, de Angelis D, Brant LJ, Harris HE, Mann AG, Ramsay ME. The burden of hepatitis C in England. J Viral Hepat. 2007 Aug; 14(8):570-6.
14. Hutchinson SJ, Roy KM, Wadd S, Bird SM, Taylor A, Anderson E, et al. Hepatitis C virus infection in Scotland: epidemiological review and public health challenges. Scott Med J. 2006 May;51(2):8-15.
15. Czarkowski MP. Hepatitis C in Poland in 2004. Przegl Epidemiol. 2006;60(3):481-6. (In Polish.)
16. Belarusian Centre of Hygiene, Epidemiology and Public Health [homepage on the Internet]. Dotsenko M. Department of Infectious Diseases, Belarusian State Medical University [cited 2008 Feb 15]. Available from: http://rcheph.by/.
17. The UK vs. Europe: losing the fight against hepatitis C. Southampton: Hepatitis C Trust; 2005.
18. Central and Eastern European Harm Reduction Network. Hepatitis C among drug users in the new EU member states and neighboring: situation, guidelines and recommendations. Vilnius: Eurasian Harm Reduction Network; 2007.
19. Kim WR. Global epidemiology and burden of hepatitis C. Microbes Infect. 2002 Oct;4(12):1219-25.
20. Alberti A, Clumeck N, Collins S, Gerlich W, Lundgren J, Palů G, et al; ECC Jury. Short statement of the first European Consensus Conference on the treatment of chronic hepatitis B and C in HIV co-infected patients. J Hepatol. 2005 May;42(5):615-24. Erratum in: J Hepatol. 2005 Dec;43(6):1098.
21. Graham CS, Baden LR, Yu E, Mrus JM, Carnie J, Heeren T, et al. Influence of human immunodeficiency virus infection on the course of hepatitis C virus infection: a meta-analysis. Clin Infect Dis. 2001 Aug 15;33(4):562-9.
22. Aceijas C, Rhodes T. Global estimates of prevalence of HCV infection among injecting drug users. Int J Drug Policy. 2007 Oct;18(5):352-8.